| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.03 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.066 | 0.04 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.04 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.095 | 0.04 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.05 |